KRAS and cancer: Notably, we demonstrate that short, transient expression of reprogramming factors in Kras mutant mice at 4 weeks of age results in persistent ERK activation and widespread PDAC development within 10 days, indicating that cellular reprogramming is sufficient for the initiation of cancer growth in pancreatic cells with Kras mutation.